Source: Outsourcing-Pharma

Acurian: Acurian, Synexus tap database of 100m for NASH patient enrollment solution

Acurian and Synexus have introduced a new clinical trial enrollment solution for patients with nonalcoholic fatty liver disease, which is often underdiagnosed.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more